PLUR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now. PLUR has no proprietary buy signals today, weak/declining fundamentals in 2026/Q1, and near-term pattern odds skew slightly negative over the next day/week. For an impatient buyer looking for immediate upside, the current setup does not offer a compelling entry.
Price is ~3.32 with key pivot at 3.245 (slightly above pivot, modestly constructive). MACD histogram is positive (0.0439) but contracting, implying bullish momentum is fading rather than accelerating. RSI(6) ~58.7 is neutral (no strong overbought/oversold edge). Moving averages are converging, consistent with a sideways-to-indecisive trend. Levels: resistance near R1 3.436 then R2 3.554; support near S1 3.054 then S2 2.936. Pattern-based forecast suggests a 60% chance of -1.02% next day and -1.64% next week, but +7.19% next month—near-term choppy/soft with a potential later rebound.
Intellectia Proprietary Trading Signals
leaves room for a push toward 3.436/3.554 if momentum returns. Pattern study indicates potential strength over the next month (+7.19%), suggesting a possible medium-term bounce if broader sentiment improves. Hedge funds and insiders are currently neutral (no heavy selling pressure flagged in the provided trend data).
No news/catalysts in the last week (lack of event-driven upside). MACD is positive but contracting (momentum cooling). Near-term statistical outlook leans negative over next day/week. Fundamentals show very small revenue base and continued losses with deteriorating margins (limits investor confidence and makes the stock more sentiment-driven).
Latest quarter: 2026/Q1. Revenue decreased to 316,000 (-3.07% YoY). Net income remained deeply negative at -5,850,000 (-0.54% YoY). EPS fell to -0.65 (-39.81% YoY). Gross margin declined to 36.39 (-40.68% YoY). Overall: shrinking revenue, worsening per-share loss, and sharply lower margins—no clear signs of improving operating trajectory in the latest quarter.
No analyst rating or price target change data was provided, so there is no observable recent trend to summarize. Wall Street pros/cons view cannot be confirmed from the dataset; in absence of coverage/updates here, the setup relies mainly on technicals and company fundamentals, which currently skew against an immediate buy.
